Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,252.80
(
-1.87%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
79,032.85
(
-0.03%
)
News Focus
News Focus
Post# of 257578
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 269
Posts 18913
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: Robert C Jonson post# 147343

Saturday, 08/18/2012 7:13:05 PM

Saturday, August 18, 2012 7:13:05 PM

Post# of 257578
I would like to know how many of those critical of PPHM's phase II 2nd or 1st line NSCLC trials have themselves designed what they consider an appropriately designed trial in an identical or substantially identical situation.

Do any of you know personally Dr. Bruce Chabner, of Harvard I believe, and his area of expertise?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today